CN104415364A - Polyacrylonitrile-containing medical high-molecular contrast agent microballoon - Google Patents
Polyacrylonitrile-containing medical high-molecular contrast agent microballoon Download PDFInfo
- Publication number
- CN104415364A CN104415364A CN201310379064.2A CN201310379064A CN104415364A CN 104415364 A CN104415364 A CN 104415364A CN 201310379064 A CN201310379064 A CN 201310379064A CN 104415364 A CN104415364 A CN 104415364A
- Authority
- CN
- China
- Prior art keywords
- microsphere
- contrast agent
- polyacrylonitrile
- layer
- silicon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention discloses a polyacrylonitrile-containing medical high-molecular contrast agent microballoon. The microballoon has a hollow type inorganic/organic/inorganic three-layer structure, a cavity is disposed at the center of the microballoon, and the interior is filled with air; the outer layer of the cavity is a Fe3O4 magnetic particle; the middle layer is a core/shell polymer nanosphere obtained through free radical copolymerization of a polyacrylonitrile-polymethacrylic acid random copolymer and polymethacrylic acid and divinyl benzene, and stabilization is realized due to the fact that the copolymer and the inner-layer Fe3O4 magnetic particle can form a coordination bond or an ionic bond through inner-surface carboxyl and a ferric salt; and the outer layer is silicon dioxide, and connection is realized due to the fact that carboxyl on the surface of the nanosphere and silanol on the surface of silicon dioxide have hydrogen-bond interaction. The material has the advantages that the polymer microballoon belongs to a nanometer level particle; the inner-layer Fe3O4 magnetic particle enables the contrast agent to realize targeted positioning; the silicon dioxide hollow microballoon has extremely good biocompatibility and mechanical stability, and the internal cavity can generate strong echo signals under a contrast mode.
Description
Technical field
The present invention relates to a kind of medical detection contrast agent, particularly relate to a kind of Nano microsphere with the multilamellar organic/inorganic composite construction of magnetic function, belong to medicine technology field.
Background technology
In recent years, molecular image technology can provide important information and be paid close attention to (Campbell R. E., Chang C. J. widely for the medical diagnosis on disease of biological tissue and monitoring due to it
curr Opin Chem Biol, 2010,14 (1): 1-2.).In numerous imaging pattern, ultra sonic imaging, as the AT biomedical imaging pattern of one, has important researching value because it has the advantages such as imaging and timely, cheap, the light and fast of diagnosis safety, utilization are extensive.But the difference of echo-signal usually can hinder the accuracy of diagnosis between different biological tissue; in order to obtain the accurate information of particular organization better; people adopt the method adding ultra sonic imaging contrast agent to realize (R. D í az-L ó PANz usually; Tsapisa N.; Libong D., et al.
biomaterials, 2009,30 (8): 1462-1472.).
Usually contrast agent used is mainly microvesicle, and its shell is that the amphipathic small molecules such as saccharide, protein or polymer are formed, inner filling C
3f
8, SF
6vesicle (Ferrara K. W., Borden M. A., Zhang H. is formed Deng gas
acc Chem Res, 2009,42 (7): 881-892.).These contrast agent can change or strengthen ultrasound echo signal and provide better surface or organizational information.But due to laplace pressure, blood pressure, oxidative metabolism and hyperacoustic effect, these gas microbubbles are just dissolved and are broken after injection blood a few second, and particle diameter is difficult to control (Schutt E. G., Klein D. H., Mattrey R. M., et al.
angew Chem Int Ed, 2003,42 (28): 3218-3235.).SiO 2 hollow microsphere has good biocompatibility and mechanical stability, and has larger cavity, can produce stronger echo-signal under imaging mode, can solve the problem.(Lin P. L., Eckersley R. J., the Elizabeth A. H. such as Hall
adv Mater2009,21 (38-39): 3949-3952.) with PAN ball for template, change surface charge by polyallyl acid hydrochloride (PAH) and prepare the tiny balloon that particle diameter is 2.8 μm, shell thickness is less than 30nm, and have studied its ultra sonic imaging effect under different mechanical index condition.Linear ultrasonic imaging (B-model) result shows, this hollow SiO
2bead has very strong ultrasonic signal under water environment.But these class methods still have certain limitation, as hollow SiO
2the size of bead is too large, does not reach nanoscale structures, is difficult to for living imaging, and does not carry out modified with functional group and be difficult to connect further.Therefore, the contrast agent of current clinical middle use can't be taken into account good biocompatibility, mechanical stability, Targeting Performance, nanostructured simultaneously, can be carried out the requirements such as modified with functional group.
Summary of the invention
The present invention is directed to above problem, provide that a kind of it is a kind of multilamellar organic/inorganic composite construction magnetic Nano microsphere containing polyacrylonitrile medical high polymer contrast agent microsphere, have hollow type inorganic/organic/inorganic three-layer composite structure:
What be positioned at microsphere center is cavity, inner filling air;
Intermediate layer is macromolecule layer, is the copolymer of polymethylacrylic acid and divinylbenzene;
Be four oxidation three body magnetic nano-particles between cavity and intermediate layer, be deposited on macromolecule layer inner surface by coordinate bond or ionic bond;
Outer for there being mesoporous Nano particles of silicon dioxide, outside with macromolecule layer by hydrogen bond action absorption.
The technical solution adopted for the present invention to solve the technical problems is:
1) preparation of core/shell polymer microsphere double-layer nanometer microsphere
This microsphere is prepared based on a kind of core/shell polymer microsphere double-layer nanometer microsphere.First utilize acrylonitrile and methacrylic acid to carry out copolymerization and obtain dispersed nano microsphere, it is structure shown in following chemical formula:
Wherein x is the integer of 5 ~ 50;
Y is the integer of 0 ~ 15;
2) the outer cross-linked structure of double-layer nanometer microsphere is prepared
Then by above-mentioned dispersed nano microsphere and polymethylacrylic acid, divinylbenzene, by Solution Free Radical copolymerization process, obtain microsphere layer structure, it is structure shown in following chemical formula:
Wherein n is the integer of 0 ~ 50
3) core/shell polymer microsphere double-layer nanometer microsphere is prepared by " from dispersion " polyreaction
Utilize the carboxyl on the surface of double-layer nanometer microsphere can produce hydrogen bond action with the silicone hydroxyl of silica surface, make silicon dioxide in aggregate surface hydrolysis and polycondensation formation shell structurre.Its interaction chemical formula is as follows:
4) preparation of hollow polymeric-silicon dioxide nanosphere
Utilize acetone to extract kernel and form hollow polymeric-silicon dioxide nanosphere structure.In reaction system, add chloroform dissolve, stirred for several hour, after utilizing chloroform to dissolve PAN core, obtain SiO
2tiny balloon, its form keeps stable and structural integrity, has a good spherical structure.Preparation process schematic diagram as shown in Figure 4;
5) preparation of magnetic macromolecular microsphere
Finally, utilize microsphere inner surface carboxyl and the iron salt being entered internal layer by silicon dioxide micropore permeation, form coordinate bond or ionic bond, by adsorbing the Fe of hollow ball inside
2+and Fe
3+deng reactant, make internal layer in conjunction with Fe 3 O 4 magnetic particle.Its reaction principle is as follows:
By above technical scheme, tool of the present invention has the following advantages: 1) have good biocompatibility containing polyacrylonitrile medical high polymer contrast agent microsphere;
2) containing polyacrylonitrile medical high polymer contrast agent microsphere, there is volume little, there is nanoscale structures, can by various human body barriers;
3) containing polyacrylonitrile medical high polymer contrast agent microsphere due to the Fe containing superparamagnetism
3o
4, therefore there is Targeting Performance;
4) stable containing polyacrylonitrile medical high polymer contrast agent microsphere material structure, mechanical stability is high.
This type of can overcome the problems such as traditional contrast agent poor stability, echo signal are weak, poor biocompatibility containing polyacrylonitrile medical high polymer contrast agent microsphere.
Accompanying drawing explanation
Fig. 1 is that this contains the structural representation of polyacrylonitrile medical high polymer contrast agent microsphere;
Fig. 2 is that this contains the particle diameter test pattern of polyacrylonitrile medical high polymer contrast agent microsphere;
Fig. 3 is that this contains the AFM scintigram of polyacrylonitrile medical high polymer contrast agent microsphere;
Fig. 4 is the preparation flow schematic diagram of hollow polymeric microspheres.
Detailed description of the invention
For making enforcement object of the present invention, technical scheme and advantage more clear, below in conjunction with the drawings and specific embodiments of the present invention, the present invention is described in detail:
As shown in Figure 1, be the structural representation containing polyacrylonitrile medical high polymer contrast agent microsphere.This Nano microsphere has hollow type machine/organic/inorganic three-layer composite structure, has successively: outermost layer be Nano particles of silicon dioxide 1.; Intermediate layer be macromolecule layer 2.; Internal layer be four oxidation three body magnetic nano-particles 3.; Be positioned at microsphere center be cavity 4., inner fill air.Wherein Nano particles of silicon dioxide layer 1. in should have meso-hole structure.
Polymethylacrylic acid-divinylbenzene crosslinking copolymerization macromolecule as macromolecule layer 2., outside adsorbs silica particle 1. simultaneously, and internal layer in conjunction with four oxidation three body magnetic nano-particles 3. as a preferably embodiment: utilize acrylonitrile and polymethylacrylic acid to carry out copolymerization and obtain internal layer microsphere, then internal layer is carried out copolymerization by polymethylacrylic acid and divinylbenzene, obtain double-deck solid nano polymer microspheres.Utilize the carboxyl on the surface of double-layer nanometer microsphere can produce hydrogen bond action with the silicone hydroxyl of silica surface, make silicon dioxide be hydrolyzed also polycondensation in aggregate surface and form shell structurre 1..Meanwhile, utilize the meso-hole structure of Nano particles of silicon dioxide, with an organic solvent method (acetone) extracts kernel and forms hollow polymeric-silicon dioxide double-layer nanometer micro-sphere structure.Finally, utilize microsphere inner surface carboxyl and iron salt can form coordinate bond or ionic bond, entered the Fe of hollow ball inside by adsorption and permeation
2+and Fe
3+deng reactant, make internal layer in conjunction with Fe 3 O 4 magnetic particle 3..
Figure 2 shows that the particle diameter test pattern utilizing dynamic light scattering method to magnetic Nano microsphere, can find out, Nano microsphere particle diameter is less than 1 micron, and particle size distribution is narrower, proves that this Nano microsphere volume is little, good dispersion.
Figure 3 shows that the AFM scanogram containing polyacrylonitrile medical high polymer contrast agent microsphere.Prove that macromolecule forms globular micelle structure homogeneous, good dispersion, does not reunite in aqueous.Be conducive to the targeting of contrast agent in body fluid to locate and dispersion.
Provide embodiment below to be specifically described the present invention; but it is worthy of note that following examples are only used to further illustrate the present invention; can not be interpreted as limiting the scope of the invention, some nonessential improvement that the person skilled in the art in this field makes the present invention according to the invention described above content and adjustment still belong to protection scope of the present invention.
Embodiment 1:
The preparation of 1. core/shell polymeric Nano microsphere
Step one: the method first adopting " from dispersion " to be polymerized prepares single dispersing (PAN-PMAA) copolymer microsphere.Acrylonitrile and each 0.2mol, AIBN(azo-bis-isobutyl cyanide of methacrylic acid is added in 500mL tri-mouthfuls of round bottom reaction bulbs) 0.98g, butyl acetate 280 mL; under nitrogen protection; constant temperature 70 DEG C reaction 12 hours; product is dried in 55 DEG C of baking ovens, obtains single dispersing (PAN-PMAA) copolymer microsphere.
Step 2: prepare core/shell polymer microsphere by seed " from dispersion " polyreaction.By each to (PAN-PMAA) copolymer microsphere 3.65g, methacrylic acid and divinylbenzene 0.038mol, AIBN 0.09 g, butyl acetate 100 mL, normal hexane 35 mL; add in reaction bulb; under nitrogen protection; constant temperature 75 DEG C reaction 13 hours, obtains two-layer core/shell polymeric Nano microsphere.
2. silicon dioxide carries out gathering at microsphere surface and forms shell structurre
With the two-layer core prepared in above-mentioned steps/shell polymeric Nano microsphere for template, generate the homogeneous and SiO of regular appearance of thickness by sol-gel process at PMAA surface in situ
2shell.Adopt St ber method (St ber W., Fink A., Bohn E.
j Colloid Interface Sci, 1968,26 (1): 62-69.), adding 55mL ammonia is catalyst, utilizes ethyl orthosilicate (TEOS) 16.5g, after poly-condensation and hydrolysis, synthesizes SiO
2.
With PMAA surface PAN core as templated deposition SiO
2time, generally can generate the independent SiO of about 35nm
2particle.Because PAN checks SiO
2adsorptivity weak, if direct PAN precipitates SiO as masterplate
2, be difficult to obtain uniform SiO
2shell structurre.And when after the surface and copolymerized PMAA of PAN core, because of the carboxyl on PMAA chain or carboxylate radical can with the hydrolyzate of ethyl orthosilicate and SiO
2the hydroxyl of particle surface forms hydrogen bond, thus induction SiO
2nucleating growth, finally forms regular shell structurre.
3. hollow type polymer-SiO
2the preparation of Nano microsphere
Get the SiO prepared in 2.7g above-mentioned steps
2core/shell polymeric Nano microsphere, adds 15mL chloroform and dissolves, stir 7 hours in reaction system, obtains SiO after utilizing chloroform to dissolve PAN core
2tiny balloon, its form keeps stable and structural integrity, has a good spherical structure.
4. the preparation of hollow type magnetic Nano microsphere contrast agent
Hollow polymer microsphere 1.2g, the FeCl of gained in above-mentioned reactions steps is added in 250mL tri-mouthfuls of round bottom reaction bulbs
3 .6H
2o 5.8g, FeCl
24H
2o 3.3g, deionized water 180mL, under nitrogen protection, stir 1h, ultrasonic 2.5h, sucking filtration, deionized water rinsing 3 ~ 5 times.Then by filter microsphere adds in deoxygenation deionized water, in 85 DEG C, drip NH under high-speed stirred
3 .h
2o adjust ph is 11 ~ 12, under nitrogen protection, and isothermal reaction 2 h.Above-mentioned microsphere is added in bag filter, with 1000 mL pure water dialysis, refreshes the water periodically.After dialysis solution membrane filtration, lyophilization obtains hollow type magnetic Nano microsphere contrast agent.
Finally it should be noted that, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although with reference to preferred embodiment to invention has been detailed description, those of ordinary skill in the art should understand, can a point technical scheme for invention be modified or be replaced on an equal basis, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of right of the present invention.
Claims (5)
1. containing a polyacrylonitrile medical high polymer contrast agent microsphere, it is characterized in that having hollow type inorganic/organic/inorganic three-layer composite structure:
1) what be positioned at microsphere center is cavity, inner filling air;
2) intermediate layer is macromolecule layer, is the copolymer of polymethylacrylic acid and divinylbenzene;
3) between cavity and intermediate layer be ferroferric oxide magnetic nano-particles;
4) skin is Nano particles of silicon dioxide.
2. one according to claim 1 is containing polyacrylonitrile medical high polymer contrast agent microsphere, and this material is prepared as follows:
1) polyacrylonitrile-methacrylic acid random copolymerization single dispersing core/shell polymeric Nano microsphere is prepared;
2) silicon dioxide is assembled at microsphere surface;
3) hollow type polymer-SiO is prepared
2nano microsphere;
4) preparation of hollow type magnetic Nano microsphere contrast agent.
3. one according to claim 1 and 2 is containing polyacrylonitrile medical high polymer contrast agent microsphere, be further characterized in that above-mentioned steps 1) in core/shell polymeric Nano microsphere of being formed be double-decker, and be all adopt polymethylacrylic acid as hydrophilic segment, it is characterized in that:
1) its internal layer is polyacrylonitrile-methacrylic acid random copolymer;
2) its skin is polymethylacrylic acid and divinyl benzene crosslinked polymer.
4. one according to claim 1 and 2 is containing polyacrylonitrile medical high polymer contrast agent microsphere, is further characterized in that: have meso-hole structure in outermost Nano particles of silicon dioxide.
5. one according to claim 1 and 2 is containing polyacrylonitrile medical high polymer contrast agent microsphere, be further characterized in that: macromolecule layer is the copolymer of polymethylacrylic acid and divinylbenzene, macromolecule has double-deck polymethylacrylic acid structure, utilizes divinylbenzene bridging between molecule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310379064.2A CN104415364A (en) | 2013-08-27 | 2013-08-27 | Polyacrylonitrile-containing medical high-molecular contrast agent microballoon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310379064.2A CN104415364A (en) | 2013-08-27 | 2013-08-27 | Polyacrylonitrile-containing medical high-molecular contrast agent microballoon |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104415364A true CN104415364A (en) | 2015-03-18 |
Family
ID=52966183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310379064.2A Pending CN104415364A (en) | 2013-08-27 | 2013-08-27 | Polyacrylonitrile-containing medical high-molecular contrast agent microballoon |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104415364A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418949A (en) * | 2017-07-31 | 2017-12-01 | 苏州凯邦生物技术有限公司 | A kind of carrier material fixed for cellulase and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004105802A1 (en) * | 2003-05-27 | 2004-12-09 | Philips Intellectual Property & Standards Gmbh | Tracer for medical imaging |
CN104338152A (en) * | 2013-08-06 | 2015-02-11 | 成都市绿科华通科技有限公司 | Medical targeting contrast agent microsphere |
CN104415359A (en) * | 2013-08-19 | 2015-03-18 | 成都市绿科华通科技有限公司 | Organic-inorganic composite hollow ultrasound imaging microsphere material |
-
2013
- 2013-08-27 CN CN201310379064.2A patent/CN104415364A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004105802A1 (en) * | 2003-05-27 | 2004-12-09 | Philips Intellectual Property & Standards Gmbh | Tracer for medical imaging |
CN104338152A (en) * | 2013-08-06 | 2015-02-11 | 成都市绿科华通科技有限公司 | Medical targeting contrast agent microsphere |
CN104415359A (en) * | 2013-08-19 | 2015-03-18 | 成都市绿科华通科技有限公司 | Organic-inorganic composite hollow ultrasound imaging microsphere material |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418949A (en) * | 2017-07-31 | 2017-12-01 | 苏州凯邦生物技术有限公司 | A kind of carrier material fixed for cellulase and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104338153A (en) | Hollow type magnetic nanoparticle contrast agent. | |
CN104338152A (en) | Medical targeting contrast agent microsphere | |
CN104415370A (en) | Polymer magnetic particle composite ultrasonic imaging microsphere | |
CN104415359A (en) | Organic-inorganic composite hollow ultrasound imaging microsphere material | |
CN104436228A (en) | Novel magnetic ferric oxide hollow microsphere contrast agent | |
CN104436226A (en) | Ultrasound diagnosis medical polymer material with targeting function | |
CN104415364A (en) | Polyacrylonitrile-containing medical high-molecular contrast agent microballoon | |
CN104415361A (en) | Composite hollow-type medical contrast medium system | |
CN104415375A (en) | Polymer ultrasonic imaging microsphere containing magnetic particles | |
CN104415374A (en) | Preparation method of targeting polymer microsphere medical contrast agent | |
CN104415356A (en) | Medical polymer contrast agent microsphere containing polymethyl acrylate | |
CN104415377A (en) | Polymer ultrasonic imaging contrast agent containing unsaturated bonds | |
CN104415360A (en) | Nano magnetic microspheric ultrasound imaging contrast medium | |
CN104415358A (en) | Composite type ultrasound imaging contrast agent preparation method | |
CN104415367A (en) | Medical ultrasonic diagnosis contrast agent hollow composite microsphere system | |
CN104415357A (en) | Magnetic targeted ultrasound imaging microsphere preparation method | |
CN104436223A (en) | Medical high-molecular polymer microspheres containing magnetic particles | |
CN104436236A (en) | Novel biocompatible polymer magnetic contrast agent | |
CN104436230A (en) | Medical polymer ultrasound imaging microspheres | |
CN104436224A (en) | Magnetic ferric oxide composite medical contrast agent | |
CN104436241A (en) | Medical ultrasound diagnosis nanometer microsphere contrast agent system | |
CN104436242A (en) | Composite nanometer microsphere system for medical diagnosis | |
CN104436245A (en) | Magnetic targeting medical diagnosis microsphere preparation method | |
CN104436235A (en) | Composite hollow microsphere ultrasound contrast agent | |
CN104415365A (en) | Biologically-compatible medical high-molecular ultrasonic imaging microballoon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150318 |